✉ Email this page to a colleague
« Back to Dashboard
Ifetroban is an investigational drug.
There have been 10 clinical trials for Ifetroban. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2011.
The most common disease conditions in clinical trials are Respiratory Tract Diseases, Respiration Disorders, and Hypertension. The leading clinical trial sponsors are Cumberland Pharmaceuticals, Vanderbilt-Ingram Cancer Center, and American Heart Association.
Recent Clinical Trials for Ifetroban
|Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) or Non-IPF Progressive Pulmonary Fibrosis||Cumberland Pharmaceuticals||Phase 2|
|Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy||Vanderbilt University Medical Center||Phase 2|
|Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy||Cumberland Pharmaceuticals||Phase 2|